Purified E255L Mutant SERCA1a and Purified PfATP6 Are Sensitive to SERCA-type Inhibitors but Insensitive to Artemisinins
about
sameAs
Expression in Yeast Links Field Polymorphisms in PfATP6 to in Vitro Artemisinin Resistance and Identifies New Inhibitor ClassesSupergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunateDrug resistance genomics of the antimalarial drug artemisininActive detergent-solubilized H+,K+-ATPase is a monomerIn vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genesCharacterization of the differences in the cyclopiazonic acid binding mode to mammalian and P. Falciparum Ca2+ pumps: a computational studyA high-yield co-expression system for the purification of an intact Drs2p-Cdc50p lipid flippase complex, critically dependent on and stabilized by phosphatidylinositol-4-phosphate.Antimalarial screening via large-scale purification of Plasmodium falciparum Ca2+-ATPase 6 and in vitro studies.PfCRT-mediated drug transport in malarial parasites.Overexpression of membrane proteins from higher eukaryotes in yeasts.Investigating the antimalarial action of 1,2,4-trioxolanes with fluorescent chemical probesLack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins.Examination of the cytotoxic and embryotoxic potential and underlying mechanisms of next-generation synthetic trioxolane and tetraoxane antimalarialsCa(2+) monitoring in Plasmodium falciparum using the yellow cameleon-Nano biosensor.Total and putative surface proteomics of malaria parasite salivary gland sporozoites.1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agentsThe purified mechanosensitive channel TREK-1 is directly sensitive to membrane tension.The molecular and cellular action properties of artemisinins: what has yeast told us?A general approach to the basiliolide/transtaganolide natural products: total syntheses of basiliolide B, epi-8-basiliolide B, transtaganolide C, and transtaganolide D.Drug Interactions With the Ca2+-ATPase From Sarco(Endo)Plasmic Reticulum (SERCA).Targeting Channels and Transporters in Protozoan Parasite Infections.Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum.
P2860
Q22061833-ED193B49-5B5C-4163-B157-34CB404988C3Q22061950-0C79FC08-E70D-46FA-89F4-A9F3516C6214Q26862789-CABD71BC-4EFB-4573-B382-89685A6DEED0Q28276805-0E096C3A-3ADB-4A10-87E8-C68DDC098722Q28484068-2D11CF91-2D97-43D6-B8CB-198C01C735DAQ29048196-B1A814F0-994B-4ED3-9B89-FFC72740CB5AQ34505721-EFC5CECD-F85D-4500-AB5E-6B0A6691BFDEQ34622701-79490785-C7AB-47B3-AF13-08C487DFF3A6Q35069586-8572F2CD-A238-469C-8E6C-CF269DEDE97DQ35214601-C7DFEF34-4FB6-413B-A0F1-5DD64639D2B5Q35610115-D75A8AD2-5D6C-4725-9407-6E248B8EFCB6Q35941360-DB4E6F2C-7CF0-4073-9D9E-78FB573CDDB4Q36327396-DD726D06-CB3B-4AFC-8512-67B6799334B5Q36719348-61B0030C-466F-4771-B549-5AA2C769C14FQ36832448-CE62F6F1-B97F-4FED-8728-4AE9BA733678Q36914067-C8402427-CA77-415B-81E7-14D3BBC68C1EQ37189498-A6AA33DC-5698-468A-A3A9-B1C1DDEA0DFBQ37698286-AFDCDE93-0AA6-4AAB-83C1-265B6E5EB6B7Q45934724-2F6A2598-9CAA-4724-8D38-4570DAB9227FQ52562558-EF948A03-232F-465E-9FB4-B44C0AD66561Q52594992-0FFD6FB6-89CD-4976-93C9-71A27555089CQ52646479-02CA6628-3548-4812-962D-0DCD75CC635B
P2860
Purified E255L Mutant SERCA1a and Purified PfATP6 Are Sensitive to SERCA-type Inhibitors but Insensitive to Artemisinins
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Purified E255L Mutant SERCA1a ...... ut Insensitive to Artemisinins
@ast
Purified E255L Mutant SERCA1a ...... ut Insensitive to Artemisinins
@en
Purified E255L Mutant SERCA1a ...... ut Insensitive to Artemisinins
@en-gb
Purified E255L Mutant SERCA1a ...... ut Insensitive to Artemisinins
@nl
type
label
Purified E255L Mutant SERCA1a ...... ut Insensitive to Artemisinins
@ast
Purified E255L Mutant SERCA1a ...... ut Insensitive to Artemisinins
@en
Purified E255L Mutant SERCA1a ...... ut Insensitive to Artemisinins
@en-gb
Purified E255L Mutant SERCA1a ...... ut Insensitive to Artemisinins
@nl
altLabel
Purified E255L mutant SERCA1a ...... ut insensitive to artemisinins
@en
prefLabel
Purified E255L Mutant SERCA1a ...... ut Insensitive to Artemisinins
@ast
Purified E255L Mutant SERCA1a ...... ut Insensitive to Artemisinins
@en
Purified E255L Mutant SERCA1a ...... ut Insensitive to Artemisinins
@en-gb
Purified E255L Mutant SERCA1a ...... ut Insensitive to Artemisinins
@nl
P2093
P2860
P50
P356
P1476
Purified E255L Mutant SERCA1a ...... ut Insensitive to Artemisinins
@en
Purified E255L mutant SERCA1a ...... ut insensitive to artemisinins
@en
P2093
Alexandre Pozza
Bertrand Arnou
Christine Jaxel
Delphine Cardi
J. D. Clausen
J. V. Moller
P2860
P304
P356
10.1074/JBC.M109.090340
P407
P577
2010-06-08T00:00:00Z
2010-08-20T00:00:00Z